Last reviewed · How we verify
Blood, nasopharyngeal swab and saliva
Blood, nasopharyngeal swab and saliva is a Biologic drug developed by Ming-Yuan Chen. It is currently in Phase 1 development.
At a glance
| Generic name | Blood, nasopharyngeal swab and saliva |
|---|---|
| Sponsor | Ming-Yuan Chen |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blood, nasopharyngeal swab and saliva CI brief — competitive landscape report
- Blood, nasopharyngeal swab and saliva updates RSS · CI watch RSS
- Ming-Yuan Chen portfolio CI
Frequently asked questions about Blood, nasopharyngeal swab and saliva
What is Blood, nasopharyngeal swab and saliva?
Blood, nasopharyngeal swab and saliva is a Biologic drug developed by Ming-Yuan Chen.
Who makes Blood, nasopharyngeal swab and saliva?
Blood, nasopharyngeal swab and saliva is developed by Ming-Yuan Chen (see full Ming-Yuan Chen pipeline at /company/ming-yuan-chen).
What development phase is Blood, nasopharyngeal swab and saliva in?
Blood, nasopharyngeal swab and saliva is in Phase 1.